Sheffield, U.K.-based Altrika set to produce a spray version of its Cryoskin donor skin cell product that can be applied in hospitals outside of a sterile surgical environment in order to reduce treatment time; the spray would be stored in individual doses so the right number of skin cells can be selected once the wound is assessed; the cells would then be thawed as the patient is being prepared
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (2)
“The key challenge is that the [storage] surface provides a good basis for the cells and that may make them more robust to the freeze-thaw cycle,” said Snell. “What we don’t know is the correct formulation to be sure we can do that in a spray format. There are certain things we need to investigate: the solution in which the cells are suspended; the rate at which you freeze and thaw; then there are questions about the shelf life.”
- 1 vote
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



